Menopause Care Standardization Threatens Midi
Midi Health
Midi’s edge shifts from simply prescribing HRT to owning the full midlife care workflow before larger platforms make menopause treatment a standard feature. Today that workflow is still deeper than general telehealth, with 45 to 60 minute visits, clinicians trained through an in house menopause fellowship, insurance based care, lab ordering, prescriptions, compounded products, and ongoing follow ups every 6 to 12 weeks. But the category is clearly moving toward standard protocols, broader clinician training, and wider payer coverage, which makes specialized care easier for scaled platforms to copy.
-
One Medical now markets menopause care directly inside its primary care offering, says providers are specially trained, and positions menopause medication prescribing as something patients can get without booking a separate specialist. That narrows the gap between a dedicated clinic and a broad primary care platform with an existing member base.
-
Competition is also rising from focused players. Elektra is expanding payer backed menopause coverage, including a recent collaboration with Aetna Better Health of Illinois, and Midi’s own competitive set includes cash pay models like Alloy and Evernow, plus lower cost navigator led care from Elektra.
-
The employer channel is getting more crowded as menopause becomes a benefits category instead of a niche service. Maven said its Menopause and Midlife program grew 300% year over year to more than 550 clients, while CVS is training clinicians and promoting menopause support across MinuteClinic and virtual care.
The next phase of competition will be decided less by who offers HRT, and more by who bundles menopause into a broader, recurring relationship. Midi is already moving that way with longevity services, supplements, and weight management. If it can become the default care layer for women in midlife, standardization in menopause treatment will expand the market more than it compresses the business.